|
RAN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.6638999995352E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.418800E-03 |
| Normal-vs-Stage2 |
4.937700E-02 |
| Normal-vs-Stage3 |
1.70039999999316E-05 |
| Normal-vs-Stage4 |
2.827400E-04 |
| Stage1-vs-Stage2 |
7.610800E-01 |
| Stage1-vs-Stage3 |
5.776100E-04 |
| Stage1-vs-Stage4 |
4.848800E-04 |
| Stage2-vs-Stage3 |
2.722500E-02 |
| Stage2-vs-Stage4 |
3.759300E-03 |
| Stage3-vs-Stage4 |
3.049200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.38079999995244E-06 |
| Normal-vs-AfricanAmerican |
9.9779000000022E-05 |
| Normal-vs-Asian |
2.290800E-01 |
| Caucasian-vs-AfricanAmerican |
7.286200E-01 |
| Caucasian-vs-Asian |
3.497800E-01 |
| AfricanAmerican-vs-Asian |
6.181600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.49280000000396E-05 |
| Normal-vs-Female |
7.73999999648112E-08 |
| Male-vs-Female |
2.480200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.201500E-04 |
| Normal-vs-Extreme_Weight |
6.439100E-03 |
| Normal-vs-Obese |
2.435200E-04 |
| Normal-vs-Extreme_Obese |
7.526000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.706200E-02 |
| Normal_Weight-vs-Obese |
8.255400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.298190E-01 |
| Extreme_Weight-vs-Obese |
1.199650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.106200E-01 |
| Obese-vs-Extreme_Obese |
1.679820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.424500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.26589999999804E-05 |
| Normal-vs-Age(61-80Yrs) |
2.438300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.290370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.644900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.041000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.007500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.454800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.634000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.765200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.879330E-03 |
| Normal-VS-Type2 PRCC |
1.5167699999985E-05 |
| Normal-VS-KIRP CIMP |
1.197660E-04 |
| Normal-VS-Unclassified PRCC |
1.459560E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.501400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.28180000003031E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.623380E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.313750E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.212000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.828500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.227710E-02 |
| Normal-vs-N1 |
1.12979999999929E-06 |
| Normal-vs-N2 |
8.333600E-02 |
| N0-vs-N1 |
2.08099999999822E-05 |
| N0-vs-N2 |
5.604000E-02 |
| N1-vs-N2 |
7.464600E-01 |
|
|
